In short: Passing mention by the host, who lists "the founder of Trupanion" among CEOs Vinall admires; Vinall does not discuss it.
48:26that the manager loves the business, is deeply, when you look back at say the founder of Trupanion or Mark Zuckerberg or so many of these CEOs that you admire, what are the tells that they're giving you a sense that they're all in? — Yeah, I think that you can narrow the universe down pretty quickly just through the mechanical method of basically rejecting all the companies where the management is a revolving door of MBAs, which is the rule rather than
In short: Neutral (was Sell at his former firm): a good product but a bad business — FCF ~2% of revenue, a ~$6B pet-insurance TAM where it holds 20% and is losing share, a $1,000/yr policy few can justify. Won't get more negative at a ~$1B cap because M&A bids have come in "around these levels." Eisman is short and "extremely negative."
Trupanion sells pet health insurance. Customers like it and it pays claims, but as a business it barely generates cash (about 2% of revenue), the market is small and it is losing share, and a roughly $1,000-a-year policy suits few households. Tunis would be negative except that buyers have bid for companies in this space at around today's price, which puts a rough floor under the stock. Eisman is more bearish and is short.
41:21I think valuation I think is still the main thing that you have to fight, Steve. It's a billion dollar market cap.
41:27Just keep in mind we've seen M&A in the space go off around these levels.
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.